Gotowa bibliografia na temat „Vasospasme intracrânien”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Vasospasme intracrânien”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Vasospasme intracrânien"
McLaughlin, N., i M. W. Bojanowski. "Occlusion des anévrismes intracrâniens rompus en présence de vasospasme symptomatique". Neurochirurgie 58, nr 2-3 (kwiecień 2012): 165–69. http://dx.doi.org/10.1016/j.neuchi.2012.02.026.
Pełny tekst źródłaLegros, V., M. Bard, D. Rouget, J. C. Kleiber, E. Gelisse i C. Lepousé. "Complications extraneurologiques des hémorragies sous-arachnoïdiennes anévrismales". Médecine Intensive Réanimation 27, nr 5 (4.07.2018): 413–20. http://dx.doi.org/10.3166/rea-2018-0055.
Pełny tekst źródłaRitzenthaler, Thomas, i Frédéric Dailler. "Usages et mésusages du Doppler transcrânien". Médecine Intensive Réanimation 33, nr 1 (29.03.2024): 83–92. http://dx.doi.org/10.37051/mir-00201.
Pełny tekst źródłaVon Langsdorff, D., J. Sedat, D. Fontaine, M. Lonjon i P. Paquis. "Embolisation sous vasospasme angiographique d’anévrismes intracrâniens rompus : une étude de 21 patients". Neurochirurgie 51, nr 5 (listopad 2005): 513–14. http://dx.doi.org/10.1016/s0028-3770(05)83512-x.
Pełny tekst źródłaRozprawy doktorskie na temat "Vasospasme intracrânien"
Mérillon, Catherine. "Suivi du vasospasme artériel de l'hémorragie méningée par le doppler transcranien". Bordeaux 2, 1991. http://www.theses.fr/1991BOR2M064.
Pełny tekst źródłaLabeyrie, Marc-Antoine. "Evaluation du traitement du vasospasme cérébral survenant après une hémorragie sous-arachnoïdienne anévrysmale". Electronic Thesis or Diss., Université Paris Cité, 2021. http://www.theses.fr/2021UNIP5243.
Pełny tekst źródłaEvidence-based medicine has gained importance in recent decades, particularly in Anglo-Saxon countries. But many common medical practices remain unvalidated to this day. In spite of an increasing limitation of these practices, there are some areas of practice with no recommendation, for better or for worse. Shouldn't the requirement for evidence to be the requirement for evaluation? These considerations guided this research on vasospasm angioplasty, a therapy that is not yet validated but is performed in routine practice in many centers. Our work consisted first of all of a review of the literature on vasospasm, delayed cerebral ischemia, and vasospasm angioplasty after subarachnoid hemorrhage due to aneurysm rupture. We also participated in the completion of a meta-analysis on the treatment of this condition (Boulouis et al. 2016). This first step highlighted contradictions in the findings on the association between vasospasm and delayed cerebral ischemia that could be attributed to biased methodologies or using tests with low sensitivity. This review also stated that there was no evidence to date for the efficacy of vasospasm. We sought in a second step to determine the link between delayed cerebral ischemia and vasospasm using a more robust methodology than employed to date (Brami et al. 2020; Simonato et al. Submission 2021). This work supported the association between vasospasm and delayed cerebral ischemia. In addition, it has allowed us to better determine the topography of vasospasm and to show in an original way that vasospasm spares vessels between 150 and 900 microns, and predominates at the level of the middle segments of cerebral arteries in almost 40%. Finally, we sought to define which angioplasty technique was the most effective. To this end, we performed a historical cohort comparison showing superiority of distal mechanical vasodilation + intravenous vasodilation (IV) over proximal mechanical vasodilation + intraarterial vasodilation as a first-line strategy. This evaluation also highlighted important limitations of the patient selection process for vasodilation, many of whom were treated too late. We also performed an inter-center comparison of 2 opposing vasospasm treatment strategies that did not show superiority of distal mechanical vasodilation + IV over a conservative attitude without vasodilation. In conclusion, our work helps define the next steps in the validation of vasospasm angioplasty by suggesting, in particular, the interest of an explanatory randomization comparing distal mechanical vasodilation + standard medical treatment vs. standard medical treatment alone
Pulcrano-Nicolas, Anne-Sophie. "Recherche de biomarqueurs circulants de la survenue du vasospasme chez des patients souffrant d'hémorragie sous-arachnoïdienne". Thesis, Sorbonne université, 2019. http://www.theses.fr/2019SORUS312.
Pełny tekst źródłaSubarachnoid hemorrhage (SAH) morbidity and mortality are not solely due to the aneurism rupture but also to the delayed neurological ischemic disorders (DNI) that could happen. Among these, vasospasm is a severe complication occurring between the 4th and 12th day after the bleeding for one third of the SAH patients. To date, there exists no predictive marker of its happening, which force physician to give any SAH patient a preventive treatment against its occurrence not exempt of severe side effects. VASOGENE cohort was built up to search by omic approaches biomarkers of vasospasm occurrence to identify at risk patients. The thesis' aim is to identify circulating biomarkers of vasospasm occurrence post SAH. Two groups of patients were present in this cohort: aSAH patients developing (VSP+) or not (VSP-) a vasospasm. A first study comparing whole blood microRNA between VSP+ and VSP- enabled us to identify has-miR-3177-3p and LHDA as good candidate biomarkers. A second work was performed on transcriptomic data comparing mRNA levels between VSP+ and VSP-. We identified another candidate gene that is currently submitted